BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37601875)

  • 1.
    Khanlari M; Wang L; Bolen CY; Otanez FSB; Furtado LV; Key L; Irwin L; Wang W; Klco JM
    EJHaem; 2023 Aug; 4(3):765-769. PubMed ID: 37601875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute myeloid leukemia with RAM immunophenotype: A new underdiagnosed entity.
    Gajendra S; Anupurba S; Gupta R; Mallick S; Panda D; Thakral D; Gupta SK; Bakhshi S; Seth R; Rai S; Prajapati VK; Singh S
    Int J Lab Hematol; 2023 Aug; 45(4):541-552. PubMed ID: 37078511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD56, HLA-DR, and CD45 recognize a subtype of childhood AML harboring CBFA2T3-GLIS2 fusion transcript.
    Zangrando A; Cavagnero F; Scarparo P; Varotto E; Francescato S; Tregnago C; Cuccurullo R; Fagioli F; Nigro LL; Masetti R; Putti MC; Rizzari C; Santoro N; Pession A; Pigazzi M; Locatelli F; Basso G; Buldini B
    Cytometry A; 2021 Aug; 99(8):844-850. PubMed ID: 33811445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Analysis of Pediatric Acute Megakaryocytic Leukemia With CBFA2T3-GLIS2 Fusion Gene.
    Du Y; Yang L; Qi S; Chen Z; Sun M; Wu M; Wu B; Tao F; Xiong H
    J Pediatr Hematol Oncol; 2024 Mar; 46(2):96-103. PubMed ID: 38315896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of specific molecular profiles in pediatric acute megakaryoblastic leukemia in non-Down syndrome.
    Hara Y; Shiba N; Ohki K; Tabuchi K; Yamato G; Park MJ; Tomizawa D; Kinoshita A; Shimada A; Arakawa H; Saito AM; Kiyokawa N; Tawa A; Horibe K; Taga T; Adachi S; Taki T; Hayashi Y
    Genes Chromosomes Cancer; 2017 May; 56(5):394-404. PubMed ID: 28063190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of CD36 as a novel addition to the immunophenotypic signature of RAM-phenotype acute myeloid leukemia and study of its clinicopathological characteristics.
    Panda D; Chatterjee G; Sardana R; Khanka T; Ghogale S; Deshpande N; Badrinath Y; Shetty D; Narula G; Banavali S; Patkar NV; Gujral S; Subramanian PG; Tembhare PR
    Cytometry B Clin Cytom; 2021 Mar; 100(2):206-217. PubMed ID: 32865882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hh/Gli antagonist in acute myeloid leukemia with CBFA2T3-GLIS2 fusion gene.
    Masetti R; Bertuccio SN; Astolfi A; Chiarini F; Lonetti A; Indio V; De Luca M; Bandini J; Serravalle S; Franzoni M; Pigazzi M; Martelli AM; Basso G; Locatelli F; Pession A
    J Hematol Oncol; 2017 Jan; 10(1):26. PubMed ID: 28109323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathologic, cytogenetic, and molecular features of acute myeloid leukemia with megakaryocytic differentiation: A report from the Children's Oncology Group.
    Chisholm KM; Smith J; Heerema-McKenney AE; Choi JK; Ries RE; Hirsch BA; Raimondi SC; Wang YC; Dang A; Alonzo TA; Sung L; Aplenc R; Gamis AS; Meshinchi S; Kahwash SB
    Pediatr Blood Cancer; 2023 May; 70(5):e30251. PubMed ID: 36789545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive Transcriptome Profiling of Cryptic
    Smith JL; Ries RE; Hylkema T; Alonzo TA; Gerbing RB; Santaguida MT; Eidenschink Brodersen L; Pardo L; Cummings CL; Loeb KR; Le Q; Imren S; Leonti AR; Gamis AS; Aplenc R; Kolb EA; Farrar JE; Triche TJ; Nguyen C; Meerzaman D; Loken MR; Oehler VG; Bolouri H; Meshinchi S
    Clin Cancer Res; 2020 Feb; 26(3):726-737. PubMed ID: 31719049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DHH-RHEBL1 fusion transcript: a novel recurrent feature in the new landscape of pediatric CBFA2T3-GLIS2-positive acute myeloid leukemia.
    Masetti R; Togni M; Astolfi A; Pigazzi M; Manara E; Indio V; Rizzari C; Rutella S; Basso G; Pession A; Locatelli F
    Oncotarget; 2013 Oct; 4(10):1712-20. PubMed ID: 24127550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute myeloid leukemia with RAM immunophenotype presenting with extensive mesenteric and retroperitoneal lymphadenopathy: A case report and review of the literature.
    Wick N; Hitto I; Welder D; Slone T; Koduru P; Fuda F; Rakheja D; Weinberg O
    Leuk Res Rep; 2022; 17():100287. PubMed ID: 34976721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CBFA2T3-GLIS2-positive acute myeloid leukaemia. A peculiar paediatric entity.
    Masetti R; Bertuccio SN; Pession A; Locatelli F
    Br J Haematol; 2019 Feb; 184(3):337-347. PubMed ID: 30592296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of Th17 and IL-23 in Peripheral Blood and Their Relationship with Immunophenotype in Patients with Acute Myeloid Leukemia].
    Peng ZY; Yang CX; San JH; Li QQ; Zhang MM; Shi B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1056-1062. PubMed ID: 35981362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deciphering the Significance of CD56 Expression in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group.
    Pardo LM; Voigt AP; Alonzo TA; Wilson ER; Gerbing RB; Paine DJ; Dai F; Menssen AJ; Raimondi SC; Hirsch BA; Gamis AS; Meshinchi S; Wells DA; Brodersen LE; Loken MR
    Cytometry B Clin Cytom; 2020 Jan; 98(1):52-56. PubMed ID: 31294507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CBFA2T3-GLIS2-dependent pediatric acute megakaryoblastic leukemia is driven by GLIS2 and sensitive to navitoclax.
    Neault M; Lebert-Ghali CÉ; Fournier M; Capdevielle C; Garfinkle EAR; Obermayer A; Cotton A; Boulay K; Sawchyn C; St-Amand S; Nguyen KH; Assaf B; Mercier FE; Delisle JS; Drobetsky EA; Hulea L; Shaw TI; Zuber J; Gruber TA; Melichar HJ; Mallette FA
    Cell Rep; 2023 Sep; 42(9):113084. PubMed ID: 37716355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic challenge in mixed phenotype acute leukemia with T/megakaryocyte or T/myeloid lineages accompanied by t(3;3).
    Jia Y; Lin D; Wang Z; Li C; Wang H; Wang J; Mi Y
    Diagn Pathol; 2022 Oct; 17(1):74. PubMed ID: 36199105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute megakaryoblastic leukemia with trisomy 3 and CBFA2T3::GLIS2: A case report.
    Gillam J; Catic A; Paulraj P; Dalton J; Lai G; Jackson-Cook C; Turner S; Ferreira-Gonzalez A; Barrie E
    Genes Chromosomes Cancer; 2022 Aug; 61(8):491-496. PubMed ID: 35294081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3.
    Scott AA; Head DR; Kopecky KJ; Appelbaum FR; Theil KS; Grever MR; Chen IM; Whittaker MH; Griffith BB; Licht JD
    Blood; 1994 Jul; 84(1):244-55. PubMed ID: 7517211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
    Liu YR; Wang YZ; Chen SS; Chang Y; Fu JY; Li LD; Wang H; Yu H; Jiang B; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):731-6. PubMed ID: 18457262
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    de Matos RRC; Ferreira GM; Bonecker S; Rouxinol M; da Costa ES; Mello FV; Abdelhay E; Ribeiro RC; Zalcberg I; Silva MLM
    Leuk Lymphoma; 2023 Dec; 64(12):2042-2046. PubMed ID: 37548333
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.